Dual irreversible kinase inhibitors: Quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2

Allan Wissner, Heidi L. Fraser, Charles L. Ingalls, Russell G. Dushin, M. Brawner Floyd, Kinwang Cheung, Thomas Nittoli, Malini Ravi, Xingzhi Tan, Frank Loganzo

Bioorganic & Medicinal Chemistry · 2007 · 75 citations · 25 references

DOIFull text

Open access

Concepts

References

25